No differences in the overall outcomes were observed when analysing comparisons only including C57BL/6 mice, mice with an age of 6–8 weeks, female mice, a colon adenocarcinoma model, a tumour start size of 50–150 mm3, beta radiation, PD-L1 inhibitors, or a simultaneous treatment schedule. Here, CD274 is linked to colon adenocarcinoma.